{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:19:12Z","timestamp":1788517152458,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.parkreldis.2026.108416","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:51:59Z","timestamp":1783601519000},"page":"108416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma cfDNA hypermethylation at SNCA intron 1 as a potential blood-based epigenetic signal in Parkinson's disease and multiple system atrophy"],"prefix":"10.1016","volume":"150","author":[{"given":"Songnian","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1460-6748","authenticated-orcid":false,"given":"Chao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6338-7080","authenticated-orcid":false,"given":"Lifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib1","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation","volume":"6","author":"Dettmer","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108416_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-022-02406-7","article-title":"Brain region-specific susceptibility of lewy body pathology in synucleinopathies is governed by \u03b1-synuclein conformations","volume":"143","author":"De Boni","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108416_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/AGINGADV.AGINGADV-D-25-00007","article-title":"Effects of tropicamide on catalepsy and motor function in a mouse model of Parkinson's disease","volume":"2","author":"Corr\u00eaa","year":"2025","journal-title":"Aging Advances"},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108416_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha\u2010synuclein as a biomarker for parkinson's disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4062\/biomolther.2020.081","article-title":"Alpha-synuclein inclusion formation in human oligodendrocytes","volume":"29","author":"Yoon","year":"2021","journal-title":"Biomolecules & Therapeutics"},{"issue":"24","key":"10.1016\/j.parkreldis.2026.108416_bib6","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1091\/mbc.e14-02-0708","article-title":"Acute increase of \u03b1-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation","volume":"25","author":"Busch","year":"2014","journal-title":"MBoC"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10571-025-01544-2","article-title":"Alpha-Synuclein pathophysiology in neurodegenerative disorders: a review focusing on molecular mechanisms and treatment advances in parkinson's disease","volume":"45","author":"Yaribash","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9766","key":"10.1016\/j.parkreldis.2026.108416_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2026.108416_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2017.04.004","article-title":"Deregulation of \u03b1-synuclein in Parkinson's disease: insight from epigenetic structure and transcriptional regulation of SNCA","volume":"154","author":"Guhathakurta","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108416_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1165\/rcmb.2019-0150TR","article-title":"A practical guide to the measurement and analysis of DNA methylation","volume":"61","author":"Singer","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.parkreldis.2026.108416_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216623","article-title":"Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer","volume":"584","author":"Damiescu","year":"2024","journal-title":"Cancer Lett."},{"issue":"7534","key":"10.1016\/j.parkreldis.2026.108416_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature14192","article-title":"Function and information content of DNA methylation","volume":"517","author":"Sch\u00fcbeler","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108416_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108416_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/genes8060148","article-title":"CpG and Non-CpG methylation in epigenetic gene regulation and brain function","volume":"8","author":"Jang","year":"2017","journal-title":"Genes"},{"issue":"18","key":"10.1016\/j.parkreldis.2026.108416_bib16","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates Alpha-Synuclein expression and is decreased in parkinson's disease patients' brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108416_bib17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","article-title":"Levels of alpha\u2010synuclein mRNA in sporadic Parkinson disease patients","volume":"21","author":"Chiba\u2010Falek","year":"2006","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108416_bib18","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","article-title":"Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD","volume":"26","author":"Kantor","year":"2018","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108416_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015522","article-title":"CpG demethylation enhances Alpha-Synuclein expression and affects the pathogenesis of parkinson's disease","volume":"5","author":"Matsumoto","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108416_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.26073","article-title":"Parkinson's disease correlates with promoter methylation in the \u03b1\u2010synuclein gene","volume":"30","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies","volume":"8","author":"Magalh\u00e3es","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2026.108416_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.645996","article-title":"Biomarkers and the role of \u03b1-Synuclein in parkinson's disease","volume":"13","author":"Du","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108416_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/mds.28421","article-title":"Hypomethylation of SNCA in idiopathic REM sleep behavior disorder associated with phenoconversion","volume":"36","author":"Li","year":"2021","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2026.108416_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic parkinson's disease","volume":"337","author":"Ai","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"13","key":"10.1016\/j.parkreldis.2026.108416_bib25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/mds.26319","article-title":"L\u2010dopa increases \u03b1 \u2010synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro","volume":"30","author":"Schmitt","year":"2015","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108416_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.parkreldis.2013.12.002","article-title":"Methylation of \u03b1-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients","volume":"20","author":"yan","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2026.108416_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2014.03.076","article-title":"Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients","volume":"569","author":"Song","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108416_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3233\/JPD-201912","article-title":"SNCA hypomethylation in rapid eye movement sleep behavior disorder is a potential biomarker for parkinson's disease","volume":"10","author":"Zhao","year":"2020","journal-title":"JPD"},{"key":"10.1016\/j.parkreldis.2026.108416_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2016.05.037","article-title":"The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population","volume":"367","author":"Wei","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/epigenomes7010005","article-title":"SNCA gene methylation in parkinson's disease and multiple System atrophy","volume":"7","author":"Eyu","year":"2023","journal-title":"Epigenomes"},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108416_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/01616412.2017.1368141","article-title":"Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions","volume":"39","author":"Eryilmaz","year":"2017","journal-title":"Neurol. Res."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108416_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mds.24907","article-title":"No evidence for differential methylation of \u03b1-synuclein in leukocyte DNA of parkinson's disease patients","volume":"27","author":"Julia","year":"2012","journal-title":"Mov. Disord."},{"issue":"6538","key":"10.1016\/j.parkreldis.2026.108416_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108416_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tig.2021.04.005","article-title":"The Nexus of cfDNA and nuclease biology","volume":"37","author":"Han","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.parkreldis.2026.108416_bib35","article-title":"The comings and goings of cell-free DNA: biological and clinical implications","author":"Malki","year":"2025","journal-title":"M\u00e9d. Sur"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13148-019-0689-y","article-title":"Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq)","volume":"11","author":"Liu","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108416_bib38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in parkinson's disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12864-019-5761-7","article-title":"Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array","volume":"20","author":"Mansell","year":"2019","journal-title":"BMC Genom."},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108416_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn122","article-title":"Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping","volume":"36","author":"Bock","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13073-017-0466-5","article-title":"Parkinson's disease is associated with DNA methylation levels in human blood and saliva","volume":"9","author":"Chuang","year":"2017","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-019-02074-0","article-title":"White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy","volume":"139","author":"Bettencourt","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"13","key":"10.1016\/j.parkreldis.2026.108416_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2026.108416_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo Nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13148-023-01585-8","article-title":"Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems","volume":"15","author":"Zhang","year":"2023","journal-title":"Clin. Epigenet."},{"issue":"7943","key":"10.1016\/j.parkreldis.2026.108416_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108416_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of Alpha-Synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2026.108416_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107321","article-title":"Aggregated \u03b1-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease","volume":"133","author":"Dimoula","year":"2025","journal-title":"Park. Relat. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108416_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02590","article-title":"Alpha synuclein in hematopoiesis and immunity","volume":"5","author":"Pei","year":"2019","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/16078454.2022.2078041","article-title":"Beyond neurodegenerative diseases: \u03b1-synuclein in erythropoiesis","volume":"27","author":"Ling","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.parkreldis.2026.108416_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105832","article-title":"Peripheral \u03b1-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder","volume":"115","author":"Arnaldo","year":"2023","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib51","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1038\/s41467-023-39652-6","article-title":"Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease","volume":"14","author":"Irmady","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108416_bib52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s43587-021-00088-6","article-title":"RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease","volume":"1","author":"Craig","year":"2021","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41531-025-01062-4","article-title":"Decreased SNCA expression in whole-blood RNA analysis of Parkinson's disease adjusting for neutrophils","volume":"11","author":"Xu","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2026.108416_bib54","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awv202","article-title":"Association between \u03b1-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease","volume":"138","author":"Locascio","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108416_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.652226","article-title":"Cell-Type specific changes in DNA methylation of SNCA intron 1 in synucleinopathy brains","volume":"15","author":"Gu","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108416_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41467-023-35959-6","article-title":"DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation","volume":"14","author":"An","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108416_bib58","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gr.275426.121","article-title":"Nuclease deficiencies alter plasma cell-free DNA methylation profiles","volume":"31","author":"Han","year":"2021","journal-title":"Genome Res."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:05:48Z","timestamp":1788516348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"alternative-id":["S1353802026002439"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108416","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma cfDNA hypermethylation at SNCA intron 1 as a potential blood-based epigenetic signal in Parkinson's disease and multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108416"}}